2001 Healthcare Leads 
European Pharmaceutical Review
JANUARY 25, 2024
They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe. 3 Moreover, digital platforms can be tailored to the needs of patients and healthcare professionals, offering accessible, trustworthy and up-to-date information on medicines precisely when required.
European Pharmaceutical Review
JULY 4, 2024
2 Approach taken by regulators in the UK The Medicines and Healthcare products Regulatory Agency regulates herbal medicines in the UK. 20 Good manufacturing practice (GMP) Commission Directive (EU) 2017/1572 (which supplemented Directive 2001/83/EC) lays out the principles and guidelines of GMP in the EU. 2012/1916).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
NOVEMBER 4, 2021
Jim Lefevere is an award-winning highly-influential agile intrapreneur with over 20 years of expertise in the consumer goods, startups, medical device, and healthcare industries. Jim has enjoyed a very diverse and successful career with progressive growth in leadership, global marketing, digital marketing, and strategy development.
PM360
OCTOBER 18, 2023
Avalere Health is purposefully built to be the leading, global commercialization partner for changemaking healthcare companies looking to maximize the value of their portfolios while connecting patients to life-changing health solutions. Healthcare is fragmented, preventing patients from accessing life-enhancing innovations quickly.
European Pharmaceutical Review
DECEMBER 19, 2022
1 However, as most biosimilars are developed by means of a complex biotechnological process in living organisms, this inevitably leads to differences between the biosimilar and the reference product. Marie Manley leads Sidley’s Life Sciences team in London and is a distinguished thought leader and adviser on EU and UK regulatory law.
PM360
NOVEMBER 12, 2024
One in three people is expected to develop a neurological condition in their lifetime, and neurological diseases are the leading cause of disability. healthcare system over $800 billion annually. Ultimately, women’s healthcare needs are unique and demand tailored solutions. Today, the urgency has never been more apparent.
Pharmaceutical Technology
OCTOBER 5, 2008
“In 2001, Japan’s Taisho Pharmaceutical tried to merge with Tanabe, but it failed due to differences in corporate culture.’ Like in many other sectors, China and India are the ones labelled as those which will lead the expansion. The sector is also attracting inbound activity from leading drugs companies.
Expert insights. Personalized for you.
98 
Let's personalize your content